drugset / Trial / NCT01110525

A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

NCT01110525

Phase 1 Completed 28 enrolled AstraZeneca
RandomizedCrossoverDouble-blindBasic science

Summary

The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the metabolism of hormones included in oral contraceptives.

Timeline

Start
2010-05
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1981 Small molecule 400 mg Oral
Subject Neovletta 21/28 Unknown

Indications

No indication recorded.